초록 ▼

The invention is drawn to silane copolymers prepared from the reaction of one or more polyisocyanates with one or more lubricious polymers having at least two functional groups, which may be the same or different, that are reactive with an isocyanate functional group and with one or more organo-func

The invention is drawn to silane copolymers prepared from the reaction of one or more polyisocyanates with one or more lubricious polymers having at least two functional groups, which may be the same or different, that are reactive with an isocyanate functional group and with one or more organo-functional silanes having at least two functional groups, which may be the same or different, that are reactive with an isocyanate functional group and at least one functional group reactive with a silicone rubber substrate. The silane copolymers of the invention can be used as coatings that are elastic when dry, lubricious when wet, and resist wet abrasion. These copolymers are useful as coatings for polysiloxane (rubber) and other difficult to coat substrates, especially for medical devices, such as catheters. These silane copolymers can contain active agents such as antimicrobials, pharmaceuticals, herbicides, insecticides, algaecides, antifoulants, and antifogging agents.

대표청구항 ▼

We claim: 1. A composition comprising a silane copolymer and from 0.1% to 50% of an active agent on the dry weight of the composition, wherein said silane copolymer comprising one or more polyisocyanates, one or more organo-functional silanes, and one or more polyols. 2. A composition according t

We claim: 1. A composition comprising a silane copolymer and from 0.1% to 50% of an active agent on the dry weight of the composition, wherein said silane copolymer comprising one or more polyisocyanates, one or more organo-functional silanes, and one or more polyols. 2. A composition according to claim 1 wherein the active agent is selected from the group consisting of antimicrobial agents, antibacterial agents, antifungal agents, antiviral agents, antibiotics, chemotherapeutic drugs, anti-inflammatory drugs, anesthetics, analgesics, vasodilation substances, wound healing agents, growth factors, cytokines, immunoglobulins, pharmaceuticals, nutraceuticals, antithrombogenic agents, antitumoral agents, antiangiogenic agents, spermicides, diagnostic agents, antifoulants, insecticides, herbicides, algaecides, antifogging agents, screening agents, and mixtures thereof. 3. A composition according to claim 1 wherein the active ingredient is selected from the group consisting of oligodynamic metals and salts thereof, zeolites comprising ions of at least one oligodynamic metal, colloids of oligodynamic metal salts, biguanides, and mixtures thereof. 4. An article of manufacture comprising a substrate and a coating wherein the coating comprises a silane copolymer and from 0.1% to 50% of an active agent based on the dry weight of the composition, wherein said silane copolymer comprises one or more polyisocyanates, one or more organo-functional silanes, and one or more polyols. 5. An article according to claim 4 wherein the active agent is selected from the group consisting of antimicrobial agents, antibacterial agents, antifungal agents, antiviral agents, antibiotics, chemotherapeutic drugs, anti-inflammatory drugs, anesthetics, analgesics, vasodilation substances, wound healing agents, growth factors, cytokines, immunoglobulins, pharmaceuticals, nutraceuticals, antithrombogenic agents, autitumoral agents, antiangiogenic agents, spermicides, diagnostic agents, antifoulants, insecticides, herbicides, algaecides, antifogging agents, screening agents, and mixtures thereof. 6. An article according to claim 4 wherein the active ingredient is selected from the group consisting of oligodynamic metals and salts thereof, zeolites comprising ions of at least one oligodynamic metal, colloids of oligodynamic metal salts, biguanides, and mixtures thereof. 7. An article according to claim 4 wherein the coating comprises multiple coating layers. 8. An article according to claim 7 wherein one or more of the coating layers comprises an agent that affects the release of the active agent from the coating. 9. An article according to claim 4 wherein the article comprises a layer of silver or a silver salt beneath the coating composition. 10. An article according to claim 4 wherein the active agent is retained in the coating. 11. An article according to claim 4 wherein the article is a medical device. 12. A medical device according to claim 4 which is selected from the group consisting of catheters, guidewires, implant devices, contact lenses, IUDs, peristaltic pump chambers, endotracheal tubes, gastroenteric feed tubes, arteriovenous shunts, condoms, and oxygenator and kidney membranes. 13. A medical device according to claim 12 which is a catheter. 14. A method for the manufacture of a coated article comprising dipping, spraying, or brushing a composition comprising a silane copolymer and at least one active agent onto the surface of the article and allowing the composition to dry, wherein said active ingredient is present in an amount from 0.1% to 50% based on the dry weight of the composition, and wherein said silane copolymer comprising one or more polyisocyanates, one or more organo-functional silanes, and one or more polyols. 15. A composition comprising a polyurethane-urea-silane copolymer and from 0.1% to 50% of an active ingredient based on the dry weight of the composition. 16. A composition comprising: (a) a silane copolymer comprising one or more polyisocyanates, one or more organo-functional silanes, and one or more polyols; and (b) from 0.1% to 50% of therapeutic agent based on the dry weight of the composition. 17. An article of manufacture comprising a substrate and a coating wherein the coating comprises a polyurethane-urea-silane copolymer and from 0.1% to 50% of an active agent based on the dry weight of the composition. 18. An article of manufacture comprising a substrate and a coating wherein the coating comprises: (a) a silane copolymer comprising one or more polyisocyanates, one or more organo-functional silanes, and one or more polyols; and (b) from 0.1% to 50% of therapeutic agent based on the dry weight of the composition.